Observational Terapevticheskii arkhiv · 2026 [Efficacy and safety of H. pylori eradication therapy in real-world clinical practice: results of the «PAMIR» observational program]. Alexeev NY, Astaf'eva TO, Vishnevskaya VV, et al. Bifidobacterium animalis PubMed ↗
Randomized trial Frontiers in cellular and infection microbiology · 2026 Probiotics alleviate oral microbiota disruptions induced by Helicobacter pylori eradication with vonoprazan-amoxicillin dual therapy: a randomized double-blind placebo-controlled trial. (An exploratory study). Wei W, Chen W, Peng R, et al. Enterococcus faecium PubMed ↗
Review Terapevticheskii arkhiv · 2026 [Probiotics' position in clinical practice: focus on the combination of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12). A review]. Gorelov AV, Kozlov RS, Andreeva IV, et al. Bifidobacterium animalis PubMed ↗
Randomized trial Scientific reports · 2025 Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study. Tokunaga E, Inoue J, Asaji N, et al. Enterococcus faecium PubMed ↗
Review Microbial pathogenesis · 2025 Plant and probiotic-based edible vaccines for Helicobacter pylori: Research status and application prospects. Ye S, Zhao J, Zhao S Lactococcus lactis PubMed ↗
Meta-analysis Frontiers in cellular and infection microbiology · 2025 Meta-analysis of H. pylori and the gut microbiome interactions and clinical outcomes. Wu X, Zhu H, Hu Y, et al. Bacteroides fragilisFaecalibacterium prausnitzii PubMed ↗
Randomized trial Nutrition journal · 2025 Impact of supplementing Limosilactobacillus fermentum MN-LF23 on the eradication of Helicobacter pylori with 14-day standard quadruple therapy: a randomized, double-blind, placebo-controlled trial. Zhao Y, Niu X, Zhang Y, et al. Bifidobacterium longum PubMed ↗
Randomized trial Journal of biomedical science · 2025 Probiotics ameliorate H. pylori-associated gastric β-catenin and COX-2 carcinogenesis signaling by regulating miR-185. Yang YJ, Wu CT, Cheng HC, et al. Bifidobacterium animalis PubMed ↗
Review Current microbiology · 2024 Is Lactococcus lactis a Suitable Candidate for Use as a Vaccine Delivery System Against Helicobacter pylori? Haghighi FH, Farsiani H Lactococcus lactis PubMed ↗
Systematic review Clinical nutrition ESPEN · 2024 Efficacy of probiotics regimens for Helicobacter pylori eradication: A systematic review, pairwise, and network meta-analysis of randomized controlled trials. Tanashat M, Abuelazm M, Abouzid M, et al. Bifidobacterium longum PubMed ↗
Randomized trial Helicobacter · 2024 Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication. Chen J, Zhang Y, Min H, et al. Enterococcus faecalisEnterococcus faeciumKlebsiella pneumoniae PubMed ↗
Review Beneficial microbes · 2023 Bifidobacterium adolescentis - a beneficial microbe. Leser T, Baker A Bifidobacterium adolescentis PubMed ↗
Review European journal of pediatrics · 2022 Are pro- and/or synbiotics beneficial in Helicobacter pylori eradication therapy in children? A narrative review. Daelemans S, Deseck V, Levy EI, et al. Bifidobacterium longum PubMed ↗
Randomized trial Nutrients · 2022 A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates. Viazis N, Argyriou K, Kotzampassi K, et al. Bifidobacterium animalis PubMed ↗
Observational Helicobacter · 2021 Helicobacter pylori and the intestinal microbiome among healthy school-age children. Lapidot Y, Reshef L, Cohen D, et al. Segatella copri PubMed ↗
Randomized trial Terapevticheskii arkhiv · 2021 [A prospective randomized comparative study of the efficacy and safety of a two-week bismuth-based quadrotherapy of Helicobacter pylori infection with the inclusion of the probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 ]. Yakovenko EP, Strokova TV, Iakovenko AV, et al. Bifidobacterium longumEnterococcus faecium PubMed ↗
The ISME journal · 2026 Bile acid metabolism dysregulation following Helicobacter pylori eradication promotes plasmid-mediated antimicrobial resistance in the gut microbiome. Zhang P, Zhao M, Cheng Z, et al. Escherichia coli PubMed ↗
BMC medicine · 2026 Impact of Helicobacter pylori infection on gut and intratumoral microbiome and its association with immunotherapy response in gastrointestinal cancer. Jia K, Chen Y, Dai D, et al. [Clostridium] leptumRuminococcus bromii PubMed ↗
Journal of agricultural and food chemistry · 2025 Inhibitory Effect of Fucoidan Combined with Bifidobacteria on Helicobacter pylori. Guo L, Xuan J, Bao S, et al. Bifidobacterium animalis PubMed ↗
International journal of medical microbiology · 2025 Lactobacillus gasseri suppresses the Helicobacter pylori-induced expression of the proliferation-associated factors HBEGF and TGF-α in gastric host cells. Somiah T, Paul P, Pilheden S, et al. Lactobacillus gasseri PubMed ↗